SEP 9, 2026 · PHASE 2 TRIAL
Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder
ClinicalTrials.gov
Phase 2 trial registration with no results posted; study is actively recruiting and designed to assess efficacy and safety of tirzepatide in binge-eating disorder.
Reported
Estimated enrollment105
Primary outcome measure 1Percent initial weight loss, Baseline to 52…
Primary outcome measure 2Change in the Number of Binge-eating episod…